Clinical Report: Systematic Review and Meta-Analysis of Risk Assessment Models for Postherpetic Neuralgia
Overview
This systematic review and meta-analysis evaluated risk prediction models for postherpetic neuralgia (PHN), finding a pooled AUC of 0.86, indicating good predictive performance.
Background
Postherpetic neuralgia (PHN) is a significant complication of herpes zoster, affecting 10%-30% of patients and leading to severe pain and decreased quality of life. With the aging population, the incidence of herpes zoster is increasing, making the identification of high-risk patients for PHN crucial for effective management. Current treatment options often yield unsatisfactory pain relief.
Data Highlights
Study Count
Sample Size Range
PHN Incidence Rate
Pooled AUC
25
90 to 8,878
6.2% to 52.9%
0.86 (0.82–0.90)
Key Findings
The area under the curve (AUC) of the models ranged from 0.71 to 0.98.
The pooled AUC from the meta-analysis was 0.86, indicating good predictive performance.
Common predictive factors for PHN included age, VAS, rash site, prodromal pain, and extent of rash.
18 studies performed internal validation, while 4 studies conducted external validation.
All included studies exhibited a high risk of bias but good applicability.
Clinical Implications
The findings indicate that current risk prediction models for PHN show promise, but their high risk of bias limits their clinical application.
Conclusion
The study indicates that the development of robust risk prediction models for postherpetic neuralgia is essential, given the current limitations in existing research.
